Showing 6411-6420 of 7281 results for "".
- Ipsen's Dysport Approved for Use in Canadahttps://practicaldermatology.com/news/20130418-ipsens_dysport_approved_for_use_in_canada/2459560/Health Canada granted a marketing authorization for Dysport (Botulinum toxin type A for injection) for the temporary improvement in the appearance of moderate to severe frown lines (glabellar lines) in adult patients younger than 65 years of age. Medicis Aesthetics Canada, a division of Valeant Phar
- Angela Bennett Appointed as La Roche-Posay VPhttps://practicaldermatology.com/news/20130418-angela_bennett_appointed_as_la_roche-posay_vp/2459561/L'Oréal USA named Angela Bennett the Vice President of La Roche-Posay. A graduate of Loyola University in Baltimore, MD where she earned a degree in Business Administration, Bennett brings a wealth of experience, having worked with many global brands and has established solid relationships wi
- BTL Aesthetics Introduces Exilis Elitehttps://practicaldermatology.com/news/20130415-btl_aesthetics_introduces_exilis_elite/2459563/BTL Aesthetics recently introduced the Exilis ELITE, its next stage device for reducing wrinkles and treating skin laxity of the face and body. Optimizing the dynamic monopolar radiofrequency (RF) technology of the original Exilis system, the new ELITE platformoptimizes the monopolar radiofrequency
- FDA Approves New Corticosteroid Spray for Psoriasishttps://practicaldermatology.com/news/20130415-fda_approves_new_corticosteroid_spray_for_psoriasis/2459564/The FDA has approved Topicort® (desoximetasone) Topical Spray, 0.25%, for the treatment of plaque psoriasis. According manufacturer Taro Pharmaceuticals, Topicort Spray is indicated for patients 18 years of age or older.
- “Dermatologist from the Heart” Program Seeks Grant Proposalshttps://practicaldermatology.com/news/20130410-dermatologist_from_the_heart_program_seeks_grant_proposals/2459567/“Dermatologist from the Heart” is a new program from La Roche-Posay that aims to support initiatives designed to enhance the quality of life for patients. The initiative will award a grant to the most compassionate project spearheaded by dermatologists that seek to enhance patients' quality of life.
- Obagi Fate Uncertain as New Details Emergehttps://practicaldermatology.com/news/20130403-obagi_fate_uncertain_as_new_details_emerge/2459573/Following a bidding war with rival Merz Pharma Group, Valeant Pharmaceuticals appears set to acquire Obagi Medical Products. Valeant's original offer came in March, when the company announced that it would acquire Obagi at $19.75 per share, in a deal worth approximately $344 million. Then, in early
- Houston Surgeon Performs Breakthrough Robotic Hair Restorationhttps://practicaldermatology.com/news/20130402-houston_surgeon_performs_breakthrough_robotic_hair_restoration/2459574/Restoration Robotics, Inc. installed its revolutionary ARTAS System at the Mosaic Clinic in Houston, TX. Dr. Rashid Rashid is one of the few hair physicians in the country to hold both MD and PhD degrees and an enhanced background in r
- Skin Cancer Foundation Inducts Dr. Amy Forman Taub into its Amonette Circlehttps://practicaldermatology.com/news/20130327-skin_cancer_foundation_inducts_amy_forman_taub_md_into_its_amonette_circle/2459579/Amy Forman Taub, MD, was recently inducted into the Skin Cancer Foundation's Amonette Circle at the American Academy of Dermatology Annual Meeting in Miami, FL. Amonette Circle is a lifetime membership comprised of physicians who make an outstanding commitment to The Skin Cancer Foundation's mission
- Kythera Biopharmaceuticals Appoints New CMOhttps://practicaldermatology.com/news/20130318-kythera_biopharmaceuticals_appoints_new_cmo/2459587/Frederick Beddingfield, III, MD, PhD has been appointed Chief Medical Officer of Kythera Biopharmaceuticals, Inc. Dr. Beddingfield is a board-certified dermatologist who joins the company from Allergan, Inc., where he most recently held the role of Vice President and Therapeutic Area Head, Dermatolo
- NeoStrata Introduces Line Lift Duohttps://practicaldermatology.com/news/20130314-neostrata_introduces_line_lift_duo/2459589/NeoStrata Company, Inc. launched the SKIN ACTIVE Line Lift featuring Aminofil™, a novel tyrosine amino acid derivative (N-Acetyl Tyrosinamide) that delivers a rapid volumizing effect in the deep skin matrix to visibly reduce deep facial lines and wrinkles. Applied together twice daily, the SKIN ACTI